Study of drug-drug interaction of the effects of gemfibrozil and rifampicin on SAR442168 in Healthy Adult Subjects

Trial Identifier: INT16726
Sponsor: Sanofi
Start Date: May 2020
Primary Completion Date: July 2020
Study Completion Date: July 2020
Condition: Multiple Sclerosis (MS)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
United States, Minnesota Saint Paul, Minnesota, United States, 55144